Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05403710

Botulinum Toxin Therapy in Hidradenitis Suppurativa

Sponsor: University of Massachusetts, Worcester

View on ClinicalTrials.gov

Summary

This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease Hidradenitis Suppurativa (HS). In this study, the investigators will test the hypothesis that inhibiting neuropeptide activity with botulinum toxin reduces pathogenic inflammation.

Official title: Targeting Nociceptors in Hidradenitis Suppurativa

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

20

Start Date

2022-06-07

Completion Date

2028-04-30

Last Updated

2025-09-15

Healthy Volunteers

No

Interventions

DRUG

Botulinum toxin

Administration of botulinum toxin (50 units/100cm2 injected intradermally) into lesional skin

Locations (1)

University of Massachusetts Chan Medical School

Worcester, Massachusetts, United States